©The Author(s) 2025.
World J Orthop. Nov 18, 2025; 16(11): 110420
Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.110420
Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.110420
Table 2 Bivariate analysis concerning the diagnosis of osteoporosis
| Variable | Osteoporosis (n = 27) | No osteoporosis (n = 97) | P value |
| Age (years), mean ± SD | 56 ± 14.6 | 53 ± 17.4 | 0.3670 |
| Time of evolution (years), mean ± SD | 11 ± 8.2 | 13 ± 11.9 | 0.4986 |
| Body mass index (kg/m2), mean ± SD | 27 ± 4 | 29 ± 5.1 | 0.0767 |
| IGF-1 (mean, IC) | 413 (173 to 1977) | 624 (212 to 1140) | 0.5186 |
| Lanreotide or octreotide, n (%) | 12 (46) | 14 (15) | 0.035a |
- Citation: Alvarez M, Rincon J, Ulloa MM, Rincon O, Mejia L, Alvarado A, Pereira A, Bernal M. Osteoporosis and fragility fractures in patients with acromegaly: A two-center cross-sectional study. World J Orthop 2025; 16(11): 110420
- URL: https://www.wjgnet.com/2218-5836/full/v16/i11/110420.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i11.110420